Novel CNS Compound
Undisclosed CNS Disorder
Key Facts
About Richter Gedeon
Richter Gedeon's mission is to improve patient lives through the research, development, and global commercialization of innovative pharmaceuticals. The company has achieved a dominant position in its core Central and Eastern European markets while expanding its international footprint, supported by a robust pipeline of 34 candidates. Its strategy is built on deep therapeutic expertise in women's health and CNS, vertical integration from API to finished product, and a disciplined approach to both organic R&D and strategic partnerships to fuel sustainable growth.
View full company profile